DiaMedica Therapeutics Inc (DMAC)
3.575
-0.12
(-3.38%)
USD |
NASDAQ |
May 08, 16:00
3.575
0.00 (0.00%)
After-Hours: 20:00
DiaMedica Therapeutics Free Cash Flow: -18.75M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.75M |
| September 30, 2023 | -17.74M |
| June 30, 2023 | -15.33M |
| March 31, 2023 | -12.80M |
| December 31, 2022 | -11.59M |
| September 30, 2022 | -11.60M |
| June 30, 2022 | -12.25M |
| March 31, 2022 | -11.84M |
| December 31, 2021 | -12.27M |
| September 30, 2021 | -12.52M |
| June 30, 2021 | -11.82M |
| March 31, 2021 | -10.57M |
| December 31, 2020 | -9.232M |
| September 30, 2020 | -8.036M |
| June 30, 2020 | -6.921M |
| March 31, 2020 | -8.948M |
| December 31, 2019 | -9.102M |
| September 30, 2019 | -9.124M |
| June 30, 2019 | -9.751M |
| March 31, 2019 | -7.913M |
| December 31, 2018 | -5.746M |
| September 30, 2018 | -4.849M |
| June 30, 2018 | -3.673M |
| March 31, 2018 | -4.066M |
| December 31, 2017 | -3.922M |
| Date | Value |
|---|---|
| September 30, 2017 | -4.203M |
| June 30, 2017 | -4.452M |
| March 31, 2017 | -3.423M |
| December 31, 2016 | -2.994M |
| September 30, 2016 | -2.266M |
| June 30, 2016 | -1.518M |
| March 31, 2016 | -1.620M |
| December 31, 2015 | -1.567M |
| September 30, 2015 | -1.146M |
| June 30, 2015 | -3.428M |
| March 31, 2015 | -2.971M |
| December 31, 2014 | -3.787M |
| September 30, 2014 | -4.144M |
| June 30, 2014 | -2.838M |
| March 31, 2014 | -4.892M |
| December 31, 2013 | -5.637M |
| September 30, 2013 | -6.617M |
| June 30, 2013 | -7.426M |
| March 31, 2013 | -6.760M |
| December 31, 2012 | -5.547M |
| September 30, 2012 | -5.386M |
| June 30, 2012 | -4.257M |
| March 31, 2012 | -3.540M |
| December 31, 2011 | -3.515M |
| September 30, 2011 | -2.760M |
Free Cash Flow Range, Past 5 Years
-18.75M
Minimum
Dec 2023
-6.921M
Maximum
Jun 2020
-11.59M
Average
-11.60M
Median
Sep 2022
Free Cash Flow Benchmarks
| NextCure Inc | -51.41M |
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.20M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.812M |
| Cash from Investing (Quarterly) | 6.124M |
| Cash from Financing (Quarterly) | -0.001M |
| Free Cash Flow Per Share (Quarterly) | -0.1004 |
| Free Cash Flow Yield | -16.17% |